CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...